News

Here you can read the latest news regarding Inven2s portfolio businesses, innovation projects and clinical studies. Every month we write longer articles in which we interview current researchers and clinicians.
Summary of the year 2023

Summary of the year 2023

Inven2 is grateful to everyone who has contributed to building business and helping patients through new inventions, clarification, clinical...

read more
Summary of 2022

Summary of 2022

In 2022, we were delighted to reach yet another level in our long-term innovation work and, not least, to note that a record number of clinical...

read more
Vital licences

Vital licences

Inven2 has long experience of licence agreements, particularly in life sciences, which dominate the portfolio. The available licences are presented...

read more